6-9 September 2018 | Kaohsiung, Taiwan

20th Asia Pacific League of Associations for Rheumatology Congress

6-9 September 2018 | Kaohsiung, Taiwan

Program

Download PDF Program

Saturday 8 September 2018
ROOM 301 Grand Hall 304A 304B 305
SESSIONS Meet the expert Sjogren’s sydrome, an update Perioperative management in patients with rheumatic diseases
CHAIRS Jie-Ruo Gu Yu-Jih Su Ning-Shen Lai, Chung-Tei Chou
0730 – 0830 SIG Group Meeting Common neck pain
David Yu
Frederick Vivino Sergio Schwartzman
SESSIONS PLENARY SESSION – 301 Grand Hall
CHAIRS Chia-Li Yu, Sandra Navarra
0830 – 0915 Analyses of genes and gene expressions in autoimmune diseases
Kazuhiko Yamamoto
0915 – 1000 Update on lupus nephritis
Michelle Petri
1000 – 1030 COFFEE BREAK & POSTER TOUR (P3) – N2 EXHIBITION HALL 1000 -1030
1030 – 1145 Industry symposium sponsored by Astellas Industry symposium sponsored by UCB
SESSIONS ACR symposium SIG
SpA
Oral paper presentation – basic IgG4 related disease
CHAIRS Yoshiya Tanaka James Wei Wen Nan Huang, Xiaofeng Zeng Ming-Fei Liu, Dong Lingli
1145 – 1210 Mechanistic role of ACPA in treatment outcomes
William Robinson
1145 – 1220
Genetic Update of SpA
Matt Brown
Adiponectin exacerbates collagen-induced arthritis in mice via enhancing B cell response
Nan Che
1145 – 1200
Update in the pathogenesis of IgG4 RD
Kung-Chao Chang
1210 – 1235 Diagnosis and treatment of fibromyalgia in spondyloarthritis
David Yu
Elevated GITRL is associated with multu-organ involvement of primary Sjogren’s syndrome and promotes pathogenic Th17/1 differentiation through mTOR pathways
Yuzhou Gan, Zhangou Li
1200 – 1215
Treatment optimization for IgG4 RD
Hitoshi Kohsaka
Epigenetics of rheumatoid arthritis
Gary Firestein
1220 – 1255
Expression of SLAMF6 and its functional significance in podocytes of lupus nephritis
Takashi Igawa
1215 – 1230
1235 – 1300 APLAR axial spondyloarthritis recommendation
Lai-Shan Tam
DNA oxidase enzyme TET3 facilitates synovial inflammation and bone destruction
Akio Kawabe
1230 – 1245
IgG4 RD cases series: experience in Hong Kong
Chak Sing Lau
GITRL inhibits the suppressivity of myeloid-derived suppressor cells and aggravates the development of experimental Sjögren’s syndrome
Ke Rui
1245 – 1300
1300 – 1430 Industry symposium sponsored by Abbvie Industry symposium sponsored by Novartis
LUNCH BREAK & POSTER TOUR (P4) – N2 EXHIBITION HALL
SESSIONS Rheumatic manifestation of infectious diseases Sjogren’s syndrome SIG
Genetics
Treatment of Interstitial Lung Disease in Idiopathic Inflammatory Myopathy
CHAIRS Sarmidi Sumariyono, Mollyza Mohd Zain Song-Chou Hsieh, Lin Jin Ahmed Saeed, Michael Tee Shih-Tzu Tsai, Waleed AlShehhi
1430 – 1455 Leprosy and Rheumatoid arthritis. Two “sides of the medal” of systemic granulomatous inflammation
Mark Goloviznin
Sjogren’s syndrome and interstitial lung disease
Yutaro Nakamura
A framework to conduct a genetic study in a rare disease for a novel treatment – an example of Takayasu arteritis and beyond
Chikashi Terao
Interstitial lung disease in antisynthetase syndrome
Guochun Wang
1455 – 1525 Rheumatic manifestation of hepatitis
Ming-Lung Yu
Sjogren’s syndrome and gene
Young Ho Lee
Genetics of Filipino lupus patients
Michael Tee
Treatment outcome of anti-MDA5 and antisynthetase antibody related lung disease
Joung-Liang Lan
1525 – 1545 Chikungunya – A rheumatologist’s perspective
Rohini Handa
Ultrasonography in Sjogren’s syndrome
Hsin-Hua Chen
Current progress for treatment of  interstitial  lung disease in idiopathic inflammatory myopathy
Masataka Kuwana
1545 – 1615 COFFEE BREAK & POSTER VIEWING – N2 EXHIBITION HALL
SESSIONS EULAR symposium SIG
OA
Oral paper presentation – clinical Translation medicine
CHAIRS Kevin Pile, Lai-Shan Tam Sakae Tanaka Kuang-Yung Huang Chang-Youh Tsai, Worawit Louthrenoo
1615 – 1655 Optimal use of old modalities
Johannes Bijlsma
1615 – 1650
Update of advances in osteoarthritis therapy
David Hunter
Anterior thoracic fatty corner lesions in T1 Magnetic Resonance Imaging are useful for axial Spondyloarthritis diagnosis
Ho Yin Chung
1615 – 1630
Targets osteoclastogenesis: from bench to brand
Deh-Ming Chang
1615 – 1640
Are peripheral arthritis, enthesitis or dactylitis associated with poorer quality of life in axial Spondyloarthritis patients? A 1-year cohort study
Yu Heng Kwan
1630 – 1645
1655 – 1715 Promises of new modalities
Iain McInnes
1650 – 1725
Addressing some recent controversies in the management of OA
Keith Lim
The role of aberrant expression of IL-23-regulated T-cell miRNAs in the immunopathogenesis of ankylosing spondylitis
Ming-chi Lu
1645 – 1700
TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases
Ping-Ning Hsu
1640 – 1705
1715 – 1725 Microenvironmental and Systematic Evaluation of the Immunome in Osteoarthritis
Ying Ying Leung
Impact of tumour necrosis factor inhibitor versus non-steroidal anti-inflammatory drug treatment on radiographic progression in early ankylosing spondylitis
Jun Won Park
1700 – 1715
Novel molecular targets in the Translational research of rheumatoid joint
Chrong-Reen Wang
1705 – 1730
1725 – 1730 Brief introduction of imaging software of knee osteoarthritis
Sakae Tanaka
Results from a 52-week, phase 2a study of an intra-articular, small molecule Wnt pathway inhibitor, SM04690, for knee osteoarthritis
Nancy Lane
1715 – 1730
1730 – 1830 Industry symposium sponsored by Jannsen & Tanabe
2000 Gala Dinner – 305